Exercise Study for Breast Cancer Survivors
Enhancing Muscle Strength and Immunity in Breast Cancer
1 other identifier
interventional
30
1 country
1
Brief Summary
This study evaluates the link between muscle health and immune health in breast cancer survivors. Regular exercise is known to improve overall survival in cancer patients but the mechanism is not known. In this study the investigators will evaluate if improving muscle mass and strength via exercise improves the immune system's ability to fight cancer. This is a one armed study where in 30 breast cancer survivors will be recruited to a 4 month exercise intervention. Increase in muscle mass and strength will be correlated with immune cell frequency and function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Nov 2019
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2019
CompletedFirst Submitted
Initial submission to the registry
December 10, 2019
CompletedFirst Posted
Study publicly available on registry
December 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedFebruary 28, 2020
February 1, 2020
7 months
December 10, 2019
February 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Change in frequency of effector memory immune cells
Effector memory cells are immune cells that can kill cancer. We will measure the frequency of these cells before and after the 16 week training program to see if they increase. Flow Cytometry techniques will be used to determine the frequency of these cells.
16 weeks of muscle resistance training
Change in frequency of central memory immune cells
Central memory cells are immune cells that are linked to poor prognosis in patients with cancer. We will measure the frequency of these cells before and after the 16 week training program to see if they decrease. Flow Cytometry techniques will be used to determine the frequency of these cells.
16 weeks of muscle resistance training
Change in frequency of regulatory immune cells
Regulatory immune cells, also called Tregs, are a type of immune cell that keeps the immune system from becoming over active. However, people with too many Treg cells might be more susceptible to cancer growth. We will measure the frequency of Tregs by Flow Cytometry before and after the 16 week training program to see if exercise reduces their frequency.
16 weeks of muscle resistance training
Change muscle mass
Dual energy x-ray absorptiometry (DEXA) scans will be used to measure the appendicular muscle mass (amount of muscle in the arms and legs) before and after the 16 week training program. The appendicular muscle mass index is calculated using the appendicular muscle mass divided by height square and is measured in kg/m\^2.
16 weeks of muscle resistance training
Change in hand grip strength
The level of hand grip strength is a good indicator of body strength. Hand grip strength will be measured in kilograms using an instrument called a dynamometer before and after the 16 week training program.
16 weeks of muscle resistance training
Change in capacity to climb stairs
The stair climb test measures the amount of power used by a participant to climb a set of stairs. Power is measured in Watts (W) and is calculated using the time taken to climb the stairs (seconds), the vertical height of the stairs (meters) and the weight (kilograms) of the participant and is a standard measure of performance. The stair climb test will be performed before and after the 16 week training program.
16 weeks of muscle resistance training
Change in upper body strength
The Chest Press Test will be used to measure upper body strength. It will be performed before and after the 16 week training program using specialized exercise equipment in the gym. This test will measure the maximum weight that be lifted by the arms and will be measured in kilograms.
16 weeks of muscle resistance training
Change in lower body strength
The Knee Extension Test will be used as a measure of lower body strength. It will be performed before and after the 16 week training program using specialized exercise equipment in the gym. This test will measure the maximum weight that be lifted by the legs and will be measured in kilograms.
16 weeks of muscle resistance training
Change in levels of inflammatory factors in the blood
The investigators will measure the levels of inflammatory and anti-inflammatory factors, called cytokines, in blood collected before and after the 16 week training program. Cytokines will be measured in picograms per milliliter.
16 weeks of muscle resistance training
Change in levels of factors called microRNAs in the blood
The investigators will measure levels of microRNAs in the blood before and after the 16 week training protocol. The microRNAs will be detected and levels measured using a technique called qPCR.
16 weeks of muscle resistance training
Secondary Outcomes (2)
Body Mass Index
1 day before, and 1 day after the 16 week muscle resistance training program
Physical activity
1 day before, and 1 day after the 16 week muscle resistance training program
Study Arms (1)
Exercise
EXPERIMENTALFour months of muscle resistance training (exercise) designed to increase muscle mass and strength. The exercise protocol includes four different lifts with weights including, squats, bench press, dead lift and overhead press. The weights for each lift will be optimized for each participant and increased as the participant adapts to the exercise routine.
Interventions
Participants will exercise under the supervision of expert personal trainers and follow an optimized exercise program tailored to the strength and fitness level of each participant. Participants will exercise for 16 weeks; 2 days a week at the gym for an hour and 2 days of the week at home for 45 minutes.
Eligibility Criteria
You may qualify if:
- Women
- Post menopausal
- Stage I - III breast cancer
- Breast cancer the only cancer
- Can exercise for 16 weeks; 2 days a week at the gym and 2 days of the week at home
- Live in the San Diego area
You may not qualify if:
- Exercise regularly in the gym.
- Are on chemotherapy or radiation therapy or have been in the past month
- Will be on chemotherapy or radiation therapy in the next 6 months
- Have a condition that will prevent them from exercising in the gym
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- San Diego Biomedical Research Institutelead
- California Breast Cancer Research Programcollaborator
- Arizona State Universitycollaborator
- Tri-City Wellness & Fitness Centercollaborator
- We Support Ucollaborator
Study Sites (1)
Aditi Narsale
San Diego, California, 92121, United States
Related Publications (1)
Narsale A, Moya R, Ma J, Anderson LJ, Wu D, Garcia JM, Davies JD. Cancer-driven changes link T cell frequency to muscle strength in people with cancer: a pilot study. J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):827-843. doi: 10.1002/jcsm.12424. Epub 2019 Apr 12.
PMID: 30977974BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna D Davies, PhD
San Diego Biomedical Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President and CEO, Professor
Study Record Dates
First Submitted
December 10, 2019
First Posted
December 23, 2019
Study Start
November 25, 2019
Primary Completion
July 1, 2020
Study Completion
December 1, 2020
Last Updated
February 28, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share